Skip to content
GLP-1/GIP/Glucagon triple agonist Pending FDA approval

Retatrutide Insurance Coverage (2026)

Simultaneously activates three receptors — GLP-1, GIP, and glucagon — producing stronger appetite suppression and metabolic effects than dual or single agonists. Average weight loss: 24% in clinical trials.

24%

Avg Weight Loss

Not yet available (pending FDA approval)

Compounded Price

Weekly

Injection Frequency

4

Dose Options

Retatrutide Insurance Coverage

Insurance coverage for Retatrutide (Pending FDA approval) varies by plan type, insurer, and medical indication. Understanding your coverage options can significantly reduce out-of-pocket costs.

Typical Coverage

  • Brand-name Pending FDA approval may be covered with prior authorization
  • Compounded Retatrutide is generally not covered by insurance
  • Coverage often depends on whether the indication is diabetes or weight loss
  • Prior authorization typically requires BMI documentation and comorbidity evidence

If You Are Not Covered

Compounded Retatrutide through telehealth providers offers an affordable alternative at Not yet available (pending FDA approval), often cheaper than many insurance copays on brand-name medications. HSA/FSA pre-tax funds can provide additional savings of 20-40%.

Get Retatrutide - Start Free Assessment This is an affiliate link. We may earn a commission at no extra cost to you.

Retatrutide FAQ

How much does Retatrutide cost?

Compounded Retatrutide costs Not yet available (pending FDA approval) through telehealth providers. Brand-name versions (Pending FDA approval) cost Not yet available (Phase 3 trials) without insurance.

How much weight can I lose on Retatrutide?

Clinical trials show an average weight loss of 24% of body weight on Retatrutide. Individual results vary based on dosage, diet, and exercise habits.

What are Retatrutide side effects?

Common side effects include nausea, diarrhea, decreased appetite, vomiting, constipation. Most side effects are temporary and resolve within 4-8 weeks as your body adjusts.

Is Retatrutide taken daily or weekly?

Retatrutide is administered as a weekly subcutaneous injection. It uses a pre-filled pen device for subcutaneous injection.

What doses is Retatrutide available in?

Retatrutide is available in 1mg, 4mg, 8mg, 12mg doses. Treatment starts at the lowest dose and increases every 4 weeks.

More About Retatrutide

Compare Other Medications